Subscribe to press release roundup

To regularly receive important releases about Endeavour Vision and portfolio companies

Title *
First name *
Last name *
E-mail *
 
May 30, 2017
Molecular Partners provides additional details on clinical studies of proprietary lead oncology asset MP0250

 
May 12, 2017
Patrick Amstutz Appointed as Chief Executive Officer

 
April 6, 2017
Molecular Partners discloses change in shareholder base

 
March 30, 2017
Symetis and Boston Scientific reach USD 435 million purchase agreement

 
March 20, 2017
Symetis launches its IPO on Euronext Paris

 
March 20, 2017
MedTech Company Launches Large €55M IPO for Artificial Heart Valves

 
March 8, 2017
VERTIFLEX, INC. COMPLETES $40 MILLION FINANCING ROUND PMA APPROVED SUPERION® DEMONSTRATING EARLY COMMERCIAL SUCCESS

 
October 28, 2016
New data on EndoStim® therapy for the treatment of gastro-esophageal reflux disease (GERD) presented at United European Gastroenterology Week 2016

 
October 19, 2016
Sophia Genetics, spécialisée dans la bio-informatique, vise les Etats-Unis

 
September 8, 2016
Chrono Therapeutics Raises $47.6 Million in Series B Financing to Advance its Clinical Platform for Personalized Drug Therapy. Kaiser Permanente Ventures Leads Round

 
June 27, 2016
Quid named a Tech Pioneer by World Economic Forum

 
May 17, 2016
EndoStim Names Rohan Hoare, Ph.D., as New President and CEO

 
May 12, 2016
EndoStim Secures $25 Million in Funding to Expand Commercialization Efforts and Conduct a Pivotal U.S. Clinical Trial

 
March 22, 2016
Endeavour establishes largest medtech fund in Europe at EUR 250m

 
November 26, 2015
Sophia Genetics reaches milestone to become the global leader in precision medicine, connecting over 100 hospitals and laboratories to form the world’s largest clinical genomics community for molecular diagnosis

 
September 2, 2015
Molecular Partners 1H 2015 Release

 
September 1, 2015
CeQur Announces $100 Million Series C Financing

 
September 1, 2015
Symetis announces intention to float on SIX Swiss Exchange

 
August 26, 2015
ReShape Medical, Inc. Completes $38 Million Series D Financing Round Led by HealthCor Partners Management, L.P. and Endeavour Vision SA to Support U.S. Commercialization of ReShape™ Integrated Dual Balloon System Following Recent Approval by the FDA.

 
July 22, 2015
GYNESONICS RAISES $43 MILLION IN EQUITY FINANCING - Endeavour Vision and Abingworth Lead Funding

 
July 21, 2015
Allergan strengthens DARPin development and discovery alliance with Molecular Partners

 
July 7, 2015
First patient enrolled in phase III study of abicipar - Molecular Partners receives USD 15 million milestone payment

 
May 20, 2015
Independent Game Developer Kobojo Closes $7M Round Series B Funding led by Oxford Capital Partners

 
May 19, 2015
CeQur Announces Publication Of Study Results On PaQ® Insulin Delivery Device To Reduce Barriers To Insulin Therapy

 
May 18, 2015
Kobojo mentioned as one of the 10 Most-Anticipated New iPhone Games by Time Magazine

 
May 8, 2015
CeQur Announces Publication of Data Demonstrating PaQ® Insulin Delivery Device Reduces Barriers to Insulin Therapy

 
April 27, 2015
Medtech Investing: Making Late-Stage Deal Pay
 
April 23, 2015
L’étoile montante des medtech suisses

 
March 19, 2015
Quid Closes USD 39m Series D Financing

 
March 17, 2015
Molecular Partners reports its results for the Financial Year 2014 ‐  A transformative year for the company

 
March 11, 2015
BIND Therapeutics Reports Fourth Quarter and Full Year 2014 Financial Results

 
March 10, 2015
BIND Therapeutics Appoints Andrew Hirsch as Acting President and Chief Executive Officer

 
March 3, 2015
HGST Announces Definitive Agreement To Acquire Amplidata

 
December 18, 2014
Merck Acquires OncoEthix, a Privately Held Oncology Company Developing Novel BET Inhibitors for Hematological and Solid Cancers

 
December 5, 2014
Total offer size of IPO reaches CHF 106.2 million after partial exercise of IPO over-allotment option

 
December 4, 2014
PneumRx Acquired by BTG plc for up to USD 475 Million

 
November 6, 2014
Molecular Partners has successfully priced its IPO post re-launch and lists its shares on SIX Swiss Exchange

 
November 6, 2014
BIND Therapeutics Announces Agreement with Merck to Develop Targeted Accurin™ Nanomedicines for Oncology

 
October 8, 2014
Molecular Partners sets the price range for its IPO at CHF 28 to CHF 35 per share – First trading day expected for 22 October 2014

 
October 6, 2014
Sophia Genetics Adds Cystic Fibrosis Analysis to Clinical Bioinformatics Portfolio

 
September 23, 2014
Molecular Partners launches IPO on SIX Swiss Exchange

 
September 22, 2014
FierceBiotech names Molecular Partners as one of its “Fierce 15” Biotech Companies of 2014

 
September 19, 2014
Kobojo Unveils New Persistent Online RPG Zodiac, Global Project Including Developers from Some of the Most Iconic Role-Playing Games in History

 
September 19, 2014
Molecular Partners appoints Steven H. Holtzman as independent non-executive member to its board of directors

 
September 12, 2014
Symetis Receives CE Mark Approval for Transfemoral Transcatheter Aortic Heart Valve System ACURATE neo™, and Launches Product With First Commercial Implantations

 
September 8, 2014
Western Digital Capital Makes Strategic Investment in Amplidata

 
September 2, 2014
Sophia Genetics Becomes the First European Company to Obtain CE-IVD Mark for Clinical use of Next Generation Sequencing Bioinformatics Pipeline for Routine Genetic Testing

 
August 19, 2014
New Dundee studio for Kobojo

 
July 22, 2014
CommProve strengthen its commitment with Cell C in Africa

 
July 8, 2014
Sophia Genetics raises Series B round led by Invoke Capital

 
July 1, 2014
Stage 3 Phase 2 study of DARPin abicipar pegol (previously MP0112) supports progressing to phase III development program

 
June 19, 2014
Bind Therapeutics enters nanomedicine collaboration with Swiss drug giant

 
June 12, 2014
Amplidata Expands Leadership Team to Support Growth

 
June 11, 2014
Amplidata Reaches New Heights In Storage Scalability and Manageability with Himalaya

 
June 11, 2014
Verizon Adopts Amplidata’s New Himalaya Storage Architecture for Cloud Storage Service

 
April 29, 2014
Amplidata and Avere Systems Redefine The Economics Of Massively Scalable High Performance NAS Storage

 
April 25, 2014
Mutants: Genetic Gladiators Brings Monster Battles to iOS, Android Platforms

 
April 10, 2014
CommProve confirm its strong presence in LATAM

 
April 10, 2014
CeQur Appoints Douglas Lawrence Chief Executive Officer

 
April 8, 2014
Epigenetic Cancer Therapy Clears Phase I

 
March 24, 2014
Amplidata Secures $11M to Drive Next Phase of Growth

 
March 5, 2014
Diabetes Care Publishes Data Demonstrating PaQ® Insulin Delivery Device Could Help People with Type 2 Diabetes Overcome Barriers to Insulin Adherence and Improve Clinical Outcomes

 
January 22, 2014
Sakura Internet Cloud Datacenter Deploys Amplidata Object Store for Cloud Archiving, Backup, and Content Delivery Services

 
January 8, 2014
CeQur to Present at the 32nd Annual J.P. Morgan Healthcare Conference

 
December 4, 2013
Roche and Molecular Partners enter into alliance to develop new cancer treatments

 
December 2, 2013
Blackhawk Network Acquires Germany-Based Prepaid Leader Retailo as Part of Ongoing International Expansion Strategy

 
November 19, 2013
Spartoo test driver of the European Google Trusted Store program

 
November 13, 2013
Amplidata Named a Leader in IDC MarketScape for Object-Based Scale-Out Storage

 
October 28, 2013
Symetis Announces a Symbolic Milestone - the 1000th Patient Implanted with ACURATE TA™

 
October 28, 2013
French Cost-Effectiveness Trial of PneumRx RePneu LVR Coil Fully Enrolled in Record Time

 
October 8, 2013
CommProve Announces New Mobile Operator Win in Asia

 
September 26, 2013
Symetis and Endoluminal Sciences enter into a license agreement to develop 3rd generation TAVI

 
September 24, 2013
Data Demonstrating Potential Benefits of Simple Insulin Delivery Device Presented at European Association for the Study of Diabetes Annual Meeting

 
September 19, 2013
BIND Therapeutics Announces Pricing of Initial Public Offering

 
September 18, 2013
CommProve Wins $2.7M New Business in Africa

 
September 9, 2013
CeQur SA Closes $27 Million Series B Financing

 
August 27, 2013
BIND Recognized by the World Economic Forum as a Technology Pioneer

 
August 19, 2013
BIND Doses First Patient in a Phase 2 Clinical Study of BIND-014 in Prostate Cancer

 
August 12, 2013
BIND Therapeutics Files Registration Statement for Proposed Initial Public Offering

 
August 12, 2013
Symetis announces successful, first time implantation of i ts ACURATE TA™ and ACURATE TF™ TAVI systems in Japan

 
April 3, 2013
Symetis' ACURATE TA(TM) Confirms Superior Results

 
February 23, 2011
BIND Biosciences named one of MIT's Technology Review 2011 TR50 - second year in a row

 
April 13, 2010
CeQur SA names Robert O'Holla EVP for Regulatory Affairs

 
Targeting Cloud-enabled Data Centers with Big Data Demands

Milpitas, CA and Pittsburgh (PRWEB) April 29, 2014
-- Amplidata, a leader in object-based software defined storage, and Avere Systems, a leading provider of enterprise storage for cloud-enabled data centers, today announced a partnership to deliver a high performance, massively scalable and efficient for cloud-enabled data centers. The combined solution offers organizations cloud-scale economics with the security, performance and flexibility of their data center. The solution is ideally suited for many industries including: life sciences, oil and gas, media and entertainment, R&D and service providers.


Changing workloads and the ever-increasing volume and value of data continue to challenge even the most efficient IT organizations. Traditional RAID-based architectures are no longer viable for today’s big data scale due to increased risk of data loss when using multi-terabyte hard drives. To address t ...

more...
© Endeavour Vision SA 2006-2017 Terms & Conditions